Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference25 articles.
1. The clinical effectiveness and cost effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review;Colquitt;Health Technol Assess,2007
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children;Hodson;Cochrane Database Syst Rev,2010
3. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration;Levey;Am J Kidney Dis,2009
4. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure;Tryggvason;J Intern Med,2003
5. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: a report of the International Study of Kidney Diseases in Children;Tarshish;Pediatr Nephrol,1996
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy;Nano Today;2024-08
2. Kidney outcomes in children with primary focal segmental glomerulosclerosis from a low- and middle- income country;Pediatric Nephrology;2024-04-23
3. Hypomagnesemia and Fractional Excretion of Magnesium (FeMg) in Children with Nephrotic Syndrome;2024-04-05
4. Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting;Pediatric Nephrology;2023-11-10
5. Childhood nephrotic syndrome;The Lancet;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3